#United States #Ann Arbor #Akadeum Life Sciences #Cayman Chemical #Cell Isolation

New Collaboration Between Cayman Chemical and Akadeum Life Sciences

A recent collaboration has been formed between Cayman Chemical, a renowned provider of life science research tools, and Akadeum Life Sciences, recognized for its innovative buoyancy-based cell separation technology. This partnership aims to distribute Akadeum's state-of-the-art cell isolation solutions to researchers focused on advancing the fields of cell and gene therapy.

Partnership Details

Under the terms of this new alliance, Cayman Chemical will serve as the distributor for Akadeum's advanced buoyant microbubble cell isolation kits. These kits represent a significant leap in cell isolation methods, offering researchers a more effective way to isolate high-purity cell populations essential for successful therapy development. Akadeum's technology is manufactured at their headquarters located in Ann Arbor, Michigan, showcasing the innovative capabilities of the local biotechnology sector.

Overcoming Challenges in Cell Isolation

The microbubble-based approach pioneered by Akadeum addresses longstanding challenges faced by researchers in obtaining highly pure cell populations without compromising cell viability. Unlike traditional methods, which can be harsh and often result in decreased cell health, Akadeum's kits provide a faster and gentler cell separation process. This is particularly crucial in early-stage research and development of therapies, where maintaining cell integrity is paramount for future success.

The simplicity of the protocols associated with Akadeum’s kits allows for seamless integration into existing laboratory workflows, enabling researchers to yield not only pure isolated cell populations but also improving recovery rates and ensuring higher viability. Such advancements open new avenues for progress in fundamental biological discoveries as well as translational research aimed at developing new therapies.

Enhancing Global Research Capacities

Brandon McNaughton, Ph.D., CEO and Founder of Akadeum Life Sciences, expressed confidence in the partnership, stating that Cayman's strong distribution network and reputation for quality tools make them an ideal collaborator. “Through this partnership, scientists worldwide will gain access to Akadeum's microbubble technology, designed to enhance purity, recovery, viability, and scalability in cell separation,” he stated. This venture is expected to significantly empower researchers across various disciplines by facilitating more robust experimental approaches.

Cayman Chemical has consistently affirmed its commitment to providing cutting-edge technologies that benefit scientific inquiry. The distribution agreement serves to solidify Cayman's reputation as a key partner for researchers engaged in diverse fields of study. Akadeum's kits, now available through Cayman, are designated for Research Use Only (RUO), making them suitable for academic and professional investigations.

For those interested in exploring these new capabilities, further information and access to the kits can be found on Cayman Chemical's official website at www.caymanchem.com/akadeum.

About Cayman Chemical

Cayman Chemical is dedicated to empowering scientists globally by providing a vast array of high-quality biochemicals, assay kits, antibodies, and proteins. Their commitment to biotechnological advancements supports the understanding of complex biological mechanisms that underlie health and disease, paving the way for new therapies to emerge. Cayman specializes in various aspects of biochemical synthesis, purification, and characterization, along with offering analytical services that contribute to research excellence.

About Akadeum Life Sciences

Akadeum Life Sciences is at the forefront of developing flotation-based separation technologies aimed at improving cell isolation processes. The company has led the industry with its introduction of pioneering innovations that enhance the scalability and gentleness of cell separation. With a vision to revolutionize human health, Akadeum's mission is to empower researchers and clinicians to generate breakthroughs in diagnostics and therapeutics that advance scientific knowledge and patient care.